Traianos, E. Y., Locke, J., Lendrem, D., Bowman, S., Hargreaves, B., Macrae, V., . . . Ng, W. (2020). Serum CXCL13 levels are associated with lymphoma risk and lymphoma occurrence in primary Sjögren’s syndrome. Rheumatol Int.

Traianos, Emmanuella Young, James Locke, Dennis Lendrem, Simon Bowman, Ben Hargreaves, Victoria Macrae, Jessica Rachael Tarn, et Wan-Fai Ng. "Serum CXCL13 Levels Are Associated With Lymphoma Risk and Lymphoma Occurrence in Primary Sjögren’s Syndrome." Rheumatol Int 2020.

Traianos, Emmanuella Young, et al. "Serum CXCL13 Levels Are Associated With Lymphoma Risk and Lymphoma Occurrence in Primary Sjögren’s Syndrome." Rheumatol Int 2020.